Feed and Additives
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Insect farming company Entocycle is launching a production system to develop insect protein as a feed alternative for livestock and aquaculture.
Royal DSM and Novozymes have launched a new feed additive that removes bacterial debris with the aim of improving feed efficiency and digestibility in broiler chickens.
In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.
US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials.
Zoetis and Elanco have both recently received approval for poultry products in the US.
Balchem has acquired Bioscreen Technologies – an Italian firm that specializes in encapsulated and fermented feed nutrition for food animals.
Evonik Industries will produce a guanidinoacetic acid (GAA) livestock feed additive, after it recently terminated a supply deal.
Danish aquafeed firm BioMar is investing Aus$56 million ($41 million) in a new production facility in Australia.
US aquafeed start-up KnipBio has added commercialization experience to its management team.
US trace minerals firm Zinpro has appointed a new dairy nutritionist for Europe, the Middle East and Northern Africa and Russia.
Biomin has offered its support for a three-year project that aims to tackle mycotoxin-related food safety issues in sub-Saharan Africa.
US firm Archer Daniels Midland (ADM) has built on its growing status as an animal nutrition leader with its second acquisition in this area during 2018.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.